ArticleInternational journal of cancer2010

BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimus.

Dingxie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.